The hemodynamic abnormalities in short-term insulin deficiency: The role of prostaglandin inhibition

Diabetes

Volumn 45, Issue 5, 1996, Pages 602-609

  Avogaro, Angelo ^a,c   Crepaldi, Cristina ^a   Piarulli, Francesco ^a   Milan, Daniele ^a   Valerio, Anna ^a   Pavan, Paola ^a   Sacerdoti, David ^a   Calabrò, Alessio ^a   Macdonald, Ian ^b   Crepaldi, Gaetano ^a   Scognamiglio, Roldano ^a   Tiengo, Antonio ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Cattedra di Malattie del Metabolisme   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ACETOACETIC ACID; ADRENALIN; BICARBONATE; C PEPTIDE; GLUCAGON; GLUCOSE; GLYCEROL; HEMOGLOBIN A1C; HEPARIN; INDOMETACIN; INSULIN; INTRALIPID; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN; SOMATOSTATIN; UREA;

ADIPOSE TISSUE; ADULT; ANION GAP; ARTICLE; BLOOD FLOW; BLOOD PH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; HYPEREMIA; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; MALE; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

EID: 0029876264     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.5.602     Document Type: Article

References (42)

1. Miles JM, Rizza RA, Haymond M, Gerich JE. Effects of acute insulin deficiency on glucose and ketone body turnover in man. Diabetes 29:926-930, 1980
2. Schade DS, Eaton RP: The regulation of plasma ketone body concentrations by counterregulatory hormones in man III. Effects of norepinephrine in diabetic man. Diabetes 28:5-10, 1979
3. Avogaro A, Cryer PE, Bier DM: Epinephrine's ketogenic effect in humans is mediated principally by lipolysis. Am J Physiol 263:E250-E260, 1992
4. Avogaro A, Valerio A, Gnudi L, Maran A, Miola M, Duner E, Marescotti MC, Iori E, Tiengo A, Nosadini R: The effects of different plasma insulin concentrations on lipolytic and kotogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans. Diabetologia 35:129-138, 1992
5. Nosadini R, Avogaro A: Ketone body metabolism in diabetes mellilus. In Diabetes Annual 6. Alberti KGMM, Krall LP, Eds. New York, Elsevier, 1901, p. 611-633
6. McGarry JD, Guest MJ, Foster DW: Ketone body metabolism in the ketosis of starvation and alloxan diabetes. J Biol Chem 245:4382-4390, 1970
7. Nosadini R, Avogaro A, Saccà L, Vigorito C, de Kreutzenberg S, Cobelli C, Toffolo G, Trevisan R, Tessari P, Tiengo A, Crepaldi C Ketone body metabolism in normal and diabetic human skeletal muscle. Am J Physiol 249.E131-E130, 1985
8. Avogaro A, Doria A, Gnudi L, Carraro A, Duner E, Brocco E, Tiengo A, Crepaldi G, Bier DM, Nosadini R Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients Am J Physiol 263. E261-E267, 1992
9. Axelrod L, Levine L: Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis. Diabetes 31:994-1001, 1982
10. Axelrod L: Insulin, prostaglandins, and the pathogenesis of hypertension. Diabetes 40:1223-1227, 1991
11. 2 during diabetic ketoacidosis. Prostaglandins Leukol Essent Fatty Acids 40:39-43, 1990
12. Quyyumi AA, Iaffaldano R, Guerrero JL, Ryan CA, Powell WJ, Axelrod L: Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes 38:1585-1594, 1989
13. Christensen NJ A reversible vascular abnormality associated with diabetes ketosis Clin Sci 38:158-5-1591, 1970
14. Gundersen HJG: Peripheral blood flow and metabolic control in juvenile diabetes. Diabetologia 10:225-231, 1974
15. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916-918, 1982
16. Insel AP: Analgesic-antipyretic and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. New York, Pergamon, 1990, p. 638-681
17. Duggan DE, Hogans AF, Kwan KC, McMahon FG: The metabolism of indomethacin in man. J Pharmacol Exp Ther 181:563-575, 1972
18. Avogaro A, Gnudi L, Valerio A, Maran A, Miola M, Opportuno A, Tiengo A, Bier DM: Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type 1 (insulin-dependent) diabetic subjects. J Clin Endocrinol Metab 76:845-850, 1993
19. Fronek A, Bernstein EF: Postocclusive reactive hyperemia in the testing of peripheral arterial system: pressure, velocity, and pulse reappearance time. In Noninvasive Diagnostic Techniques in Vascular Disease Bernstein EF, Ed. St. Louis, Mosby, 1985, p. 584-590
20. Calabrò A, Piarulli F, Milan D, Rossi A, Coscetti G, Crepaldi G Clinical assessment of low molecular weight heparin effects in peripheral vascular disease. Angiology 44:188-195, 1993
21. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 311:689-694, 1994
22. Guaret P, Meerbauer S, Wyatt HL, Uchiyama T, Lang TW, Corday E: Two-dimensional echocardiographic quantitation of left ventricular volumes and ejection fraction. Circulation 62:308-1319, 1980
23. 1c in normal gestational diabetic and diabetic women. Diabetes 25:1118-1122, 1970
24. Lloyd B, Burrin J, Smythe P, Alberti KGMM: Enzymic fluorimetric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol and 3-hydroxybutyrate. Clin Chem 24:1724-1720, 1978
25. Price CP, Lloyd B, Alberti KGMM: A kinetic spectrophotometric assay for rapid determination of acetoacetate in blood. Clin Chem 23.1893-1897, 1977
26. Shimuzu S, Inque K, Tani Y, Yamada H: Enzymatic microdetermination of serum free fatty acids. Anal Biochem 98:341-345, 1978
27. Kuzuya H, Blix PM, Horowitz DL, Steiner DF, Rubenstein AH: Determinations of free and total insulin and C-peptide in insulin treated diabetics. Diabetes 20:22-29, 1977
28. Faloona GR, Hunger R: Glucagon. In Methods of Hormone Radioimmunoassay Jaffe BM, Behrman HR. New York, Academic, 1974, p. 317-333
29. Macdonald LA, Lake D: An improved technique for extracting catecholamines from body fluids J Neurosci Methods 13:239-242, 1985
30. VanSlyke DD, Sendroy J, Hastings AB, Neill JM: Studies of gas and electrolyte equilibria in blood. X. The solubility of carbon dioxide at 38°C in water, salt solution, serum, and blood cells. J Biol Chem 78:765-799, 1928
31. Powell WS: Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 20.947-957, 1980
32. Faris I, Vagn Nielsen H, Henrikson O, Parving HH, Lassen NA. Impaired autoregulation of blood flow in skeletal muscle and subcutaneous tissue in long-term type 1 (insulin-dependent) diabetic patients with microangiopathy. Diabetologia 25:486-488, 1983
33. Kastrup J, Norgaard T, Parving HH, Henriksen O, Lassen NA: Impaired autoregulation of blood flow in subcutaneous tissue of long term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunction. Diabetologia 28:711-717, 1985
34. Parving HH, Viberti GC, Keen H, Christensen JS, Lassen NA: Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32:943-949, 1983
35. Green JH, Macdonald IA The influence of intravenous glucose on body temperature Q J Exp Physiol 66:465-473, 1981
36. Houben AJHM, Schaper NC, Nieuwenhuijzen Kruseman AC: Acute effects of local hyperglycemia on peripheral blood flow in man. Diabetic Med 10:39-43, 1992
37. Tomlison KC, Gardiner SM, Hebden RA, Bennet T: Functional consequences of streptozotocin-induced diabetes mellitus with particular references to the cardiovascular system. Pharmacol Rev 44:103-100, 1992
38. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus Circulation 87(Suppl. V).V67-V76, 1993
39. Mathiesen ER, Hilsted J, Feldt-Kasmussen B, Bonde Petersen F, Christensen NJ, Parving HH: The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 34:1301-1305, 1985
40. Waheremberg H, Lonnqvist F, Engfeldt P, Arner P: Abnormal action of catecholamines on lipolysis in adipocytes of type I diabetic patients treated with insulin. Diabetes 38.524-533, 1989
41. Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE: Enhanced glycemic responsiveness to epinephrine in insulin dependent diabetes mellitus is the result of the inability to secrete insulin: augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenetic response to epinephrine in humans. J Clin Invest 75:1842-1851, 1985
42. Bulow J, Madsen J: Influences of blood flow on fatty acid mobilization from lipolytically active adipose tissue. Pfluegers Arch Eur J Physion 390:169-174, 1981